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Abstract
Background: Partnership for Health-2 (PFH-2) is a web-based version of Partnership for Health, an evidence-based
smoking cessation intervention for childhood cancer survivors. This paper describes the PFH-2 intervention and
baseline data collection.
Methods: 374 childhood and young adult cancer survivors were recruited from five cancer centers and
participated in the baseline assessment. At baseline, participants completed measures of their smoking behavior,
self-efficacy and stage of change for quitting smoking as well as psychological and environmental factors that
could impact their smoking behavior.
Results: At baseline, 93% of survivors smoked in the past seven days; however, 89% smoked a pack or less during
this period. Forty-seven percent were nicotine dependent, and 55% had made at least one quit attempt in the
previous year. Twenty-two percent of survivors were in contemplation for quitting smoking; of those 45% were
somewhat or very confident that they could quit within six months. Sixty-three percent were in preparation for
quitting smoking; however, they had relatively low levels of confidence that they could quit smoking in the next
month. In multivariate analyses, stage of change, self-efficacy, social support for smoking cessation, smoking policy
at work and home, fear of cancer recurrence, perceived vulnerability, depression, BMI, and contact with the
healthcare system were associated with survivors’ smoking behavior.
Discussions/Conclusions: A large proportion of the sample was nicotine dependent, yet motivated to quit.
Individual- interpersonal- and environmental-level factors were associated with survivors’ smoking behavior.
Smoking is particularly dangerous for childhood and young adult cancer survivors. This population may benefit
from a smoking cessation intervention designed to build self-efficacy and address other known predictors of
smoking behavior.
Background
It is estimated that there are 328,656 survivors of child-
hood cancer in the United States [1]. Due to advances
in cancer treatment, 80% of children diagnosed with
cancer will survive longer than five years [2]. The treat-
ments for childhood cancers can precipitate late-onset
health problems such as damage to vital organs and
treatment-related second cancers; smoking may exacer-
bate the late effects of cancer treatment [3-9]. The care
and management of survivors now includes prevention
of adverse late effects and second primary cancers. It is
critical that this group refrain from tobacco use and
other health-risk behaviors that may further increase
their risk for health problems.
Studies designed to describe smoking behavior among
childhood cancer survivors have found that this
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population [10] and age-matched controls [11]. How-
ever, a substantial number of childhood cancer survivors
still smoke [12-14]. For example, among participants in
the Childhood Cancer Survivors Study (CCSS), a colla-
borative, multi-institutional study comprised of long-
term survivors of childhood cancer, 28% reported ever
smoking and 17% were current smokers [12]. Data from
the population-based cohort in the UK, The British
Childhood Cancer Survivor Study, found that approxi-
mately 20% were current smokers [15]. These data indi-
cate that a large number of childhood cancer survivors
smoke, and interventions are needed to address tobacco
use in this high-risk population.
Partnership for Health (PFH), a randomized smoking
cessation intervention, was designed to increase survi-
vors’ motivation and self-efficacy to quit smoking [12].
Participants were randomized to one of two conditions:
(1) self-help (SH) and peer-delivered telephone counsel-
ing (PC). Participants in the SH condition received a let-
ter from the study physician about the importance of
not smoking and a smoking-cessation manual developed
specifically for survivors. Participants in the PC condi-
tion received a written feedback report tailored to their
unique cancer history and smoking behaviors, up to six
peer-delivered telephone counseling calls, and free nico-
tine replacement therapy for themselves and spouse/sig-
nificant other if they wanted to quit. PFH effectively
decreased tobacco use: the PC condition had a signifi-
cantly higher quit rate compared with the SH condition
at the eight month (16.8% v 8.5%; p < .01) and 12
month (15% v 9%; p < .01) follow ups [16]. In addition,
long-term smoking cessation (assessed 2-6 years after
baseline) was significantly higher in the PC vs. SH con-
dition [17]. Details of PFH have been published else-
where [18].
The efficacy of PFH suggested that this program could
benefit the broader population of childhood cancer sur-
vivors who smoke, thus addressing a need for services
not consistently provided by the majority of pediatric
cancer treatment facilities [19]. However, research is
needed to determine how to disseminate PFH, while
maximizing intervention efficacy. PFH-2 was developed
to test a web-based version of PFH, which could be dis-
seminated broadly through existing cancer survivorship
clinics and other settings, in comparison with the PFH
print materials. Web-based interventions have several
potential advantages. First, they enable researchers to
easily tailor intervention content based on participants’
characteristics, which has been shown to improve inter-
vention efficacy [20]. In addition, web-based interven-
tions make it possible to deliver both static information
and interactive content to a geographically diverse study
population. Further, there is some evidence that web-
based smoking cessation interventions, are more effec-
tive at changing behavior than other interventions [21].
The goals of this paper are to describe the PFH-2 inter-
vention, present data on the baseline characteristics of
the study population, and explore psychosocial and
environmental factors associated with childhood cancer
survivors’ baseline smoking rate, nicotine dependence,
and quit attempts.
Methods
Eligibility Criteria and Sample Recruitment
PFH-2 was conducted in collaboration with five cancer
centers in the United States and Canada: St. Jude Chil-
dren’s Research Hospital, Memorial Sloan Kettering
Cancer Center, Princess Margaret Hospital, The Hospi-
tal for Sick Children, and Dana-Farber Cancer Institute
(DFCI)/Partners. To be eligible, survivors had to be
diagnosed with cancer before age 35, currently between
ages 18-55, not currently treated for cancer and out of
treatment for ≥ two years, mentally able to provide
informed consent, reachable by telephone, able to speak
English, and a current smoker (defined as having
smoked at least one puff in the last 30 days).
This study was approved by the institutional review
boards at all participating institutions. Baseline data for
PFH-2 were collected from 2005-2008. A preliminary
screen for eligiblity was performed at each site. Due to
the variability in institutional implementation of patient
privacy and Institutional Review Board requirements,
the recruitment procedures varied across institutions.
However, across all sites, potentially eligible survivors
were sent an introductory letter about the study and
were given the opportunity to opt-out of further contact
by calling a site-specific project phone number men-
tioned in the introductory letter. After consent was
obtained, contact information was forwarded to the
study survey team, who verified eligibility and adminis-
tered the baseline survey. The study was also advertised
on Web sites designed for and about childhood and
young adult cancer survivors and survivorship (e.g.,
American Cancer Society, Planet Cancer, The Doug
Ulman Fund), and survivors could proactively contact
the study team and give verbal consent.
The introductory letter was sent to 4,345 cancer survi-
vors and 4,312 did not opt out of further contact. In
addition, 54 people contacted the study directly from
postings on the Websites. Of the 4,348 survivors who
were contacted, 18% (n = 733) were alive and eligible
(ineligibility largely due to smoking status), and 48% (n
= 374) of eligible survivors were enrolled in the study.
PFH-2 Study Design
PFH-2 is a randomized controlled trial with a two-group
stage stratified design and the individual as the primary
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ticipants are randomized to one of two intervention
conditions, stratified by study site: (1) Web Intervention
or (2) Print Materials Intervention.
Web Intervention
The Web Intervention includes: (1) a letter encouraging
smoking cessation from the site oncologist, developed
based on the principles of the NCI’s5A ’ss m o k i n g
counseling guidelines; (2) free pharmacotherapy for par-
ticipants and their spouses/partners; and (3) a tailored
web-based intervention.
Participants randomized to the tailored web-based
i n t e r v e n t i o na r ea s s i g n e dau n i q u eu s e r n a m ea n dp a s s -
word to access the site. This will enable us to track
their progress through the site including time spent on
the website and use of different website features.
Although participants always have access to the entire
website, they are directed through seven discrete ses-
sions designed to parallel the counseling sessions of the
original PFH study.
The web intervention was guided by principles from
Social Cognitive Theory, The Transtheoretical Model,
and the Precaution Adoption Process Model [22-24].
The goals of the intervention are as follows: (1) assess
and enhance participants’ motivation to change, (2)
address participants’ ambivalence about behavior
change; (3) provide social support, (4) assess and build
participants’ self-efficacy; (4) increase participants’
awareness of risks; (5) help participants identify and
address barriers to change; and (6) address participants’
nicotine dependence. To meet these goals, intervention
content is tailored based on participants’ motivation to
quit smoking. Participants can reassess their stage of
readiness to quit at any point during the intervention;
and at weeks 10 and 18 participants will be prompted to
reassess their stage of readiness before entering the web-
site. If participants move to an earlier or later stage of
readiness, they will automatically be given the version of
the website that is tailored to their current level of moti-
vation to quit smoking.
The site is designed to take participants back to key
pieces that they had not yet navigated, depending on
their stage of readiness for smoking cessation. However,
participants can also override the system and visit all
parts of the website. In addition, each time a participant
logs into the site, the system gives them feedback show-
ing them where they have been and suggests possible
next stops. Fresh content posted to the website and con-
tent that the participant has not seen is also highlighted.
The website also includes extensive information about
how to live a healthy lifestyle, news stories that are rele-
vant to childhood cancer survivors, information about
advances in treatment for childhood cancer, late effects,
and other relevant medical topics as well as and a
forum where study participants have the option of shar-
ing their thoughts and ideas about different topics.
To replicate the peer-to-peer nature of PFH, the Web
intervention uses a peer counselor trained in motiva-
tional interviewing to moderate the web site’s discussion
forum and serve as a resource for participants to contact
with questions. Scheduled reminder emails and a bi-
weekly newsletter about new study findings published in
cancer survivorship are used to encourage frequent use
of the website.
Materials Intervention
The Materials Intervention includes the following: (1) a
letter encouraging smoking cessation from the site oncol-
ogist, developed based on the principles of the NCI’s5
A’s smoking counseling guidelines; (2) free pharma-
cotherapy for participants and spouses/significant others
who want to quit; and (3) tailored and targeted self-help
materials addressing participant-specific barriers to
change and other survivor-related topics of interest.
Data Collection Procedures
Baseline data were collected by telephone prior to inter-
vention condition assignment. These data were used to
characterize participants’ smoking behavior, self-efficacy
and stage of change for quitting smoking as well as psy-
chological and environmental factors that could impact
their smoking behavior.
Measures
Socio-Demographic Characteristics, Body Mass Index
(BMI), and Medical History
The following demographic data were collected: age,
gender, race, ethnicity, marital status, education, and
employment status. We also collected self-reported data
on height and weight in order to calculate BMI. In addi-
tion, self-reported data were also collected on partici-
pants’ type of cancer and cancer treatment.
Internet access and utilization were measured with a
series of questions about whether participants owned a
computer, whether they had access to the internet at
home and/or work, how frequently they used a compu-
ter, and how frequently they checked e-mail or used the
internet.
Smoking behavior
Smoking rate: participants reported the number of cigar-
ettes they smoked per day. Nicotine dependence: partici-
pants reported the number of minutes after waking that
they smoked their first cigarette [25]; responses were
dichotomized as < 30 minutes (nicotine dependent) and
≥ 30 minutes (not nicotine dependent). Quit attempts:
participants reported the number of times in the pre-
v i o u s1 2m o n t h st h a tt h e yt r i e dt oq u i ts m o k i n ga n d
stayed off cigarettes for at least 24 hours. Use of
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whether participants had ever used Zyban or nicotine
replacement therapy to quit smoking.
Smoking-Related Motivational Variables
T h eS t a g e so fC h a n g eS c a l ew a su s e dt oa s s e s sm o t i v a -
tion to quit smoking [26], according to four categories:
(1) precontemplation: not seriously thinking about quit-
ting smoking in the next six months; (2) contemplation:
seriously thinking about quitting smoking in the next
six months; (3) preparation: intending to quit smoking
in the next month and those who have tried to quit in
the past year; (4) action: not currently smoking and quit
within the past six months or maintenance: have not
smoked for at least six months. Self-efficacy was
assessed with two questions about participants’ level of
confidence that they could quit smoking in six months
and one month respectively [18].
Social Environment
Social support for smoking cessation was assessed with a
series of questions about whether participants’ family,
friends, coworkers, and health care providers encour-
aged them to quit smoking. We also asked whether par-
ticipants’ spouse or partner smoked [16]. Household
and workplace smoking policy: Participants were asked
to characterize the rules about smoking at home and
work. Response options captured whether smoking was
unrestricted inside the building/house, limited to certain
rooms, or forbidden inside the building/house.
Psychological Variables
Fear of cancer recurrence was assessed with a question
about whether in the previous week, participants wor-
ried about getting cancer again. Fear of recurrence was
also assessed with the Intrusive Thoughts sub-scale of
the Impact of Events Scale (IES), which measures the
frequency with which thoughts intrude into conscious-
ness [27]. Perceived control was assessed with the 3-
item Perceived Control Scale, which measure the degree
to which participants felt they could control the physical
side effects, future health, and chance of a cancer recur-
rence [28]. Perceived vulnerability was assessed with a
question about perceived risk of any serious future
health problem. Perceived vulnerability was also assessed
with the Perceived Importance of Health Protection
scale, which assesses survivors’ perceptions of their vul-
nerability to tobacco-related health risks relative to age
and gender matched peers [29]. Depression was mea-
sured with the 2-item Prime MD scale, which asks
about feelings of depression and loss of interest or plea-
sure during the previous month [30]. Respondents who
answered “yes” to either question were classified as
screening positive for possible depression [30].
Contact with the Healthcare System
Participants were asked whether they had a regular
healthcare provider and whether they had been seen by
their primary care physician or their oncologist in the
past year. Participants were also asked if they had been
hospitalized in the past year.
Data Analysis
Descriptive analyses were used to characterize the study
population. Multinomial logistic regression was used to
identify predictors of participants’ smoking rate, nicotine
dependence, and number of quit attempts in the past
year. A step-wise selection approach was used to enter
variables into the model. Variables significant at p ≤ .25
in the bivariate analysis were entered into the multivari-
ate model. Those variables that remained significant at
p ≤ .15 were retained in the model. The following pre-
dictors, selected based on our and others’ previous
work, were examined: BMI, stage of change, self efficacy,
social support for smoking cessation, fear of cancer
recurrence, intrusive thoughts, perceived control, per-
ceived vulnerability, depression, contact with the health-
care system and smoking policy at work and home.
Smoking behavior differed by recruitment site, cancer
treatment, and time since diagnosis, so we adjusted for
these variables in our analysis. In addition, we adjusted
for age, gender, race and education, cancer diagnosis, as
well as the two smoking behaviors not being analyzed.
Results
Participant Characteristics
The mean age at enrollment was 32.4 (s =7 . 9 4 ) .T h e
sample was 51% male, 86% white, and 30% had at least
a college degree. In addition, 48% were married or living
with a partner, and 80% were employed in the last year.
The mean years since cancer diagnosis was 20 (s =
9.61), and leukemia was the most common type of can-
cer diagnosis reported by study participants (23%).
Eighty-one percent of the sample owned their own com-
puter, 82% had access to the Internet at home and/or
work, and 77% used the Internet at least once per week.
Smoking Behavior and Stage of Change
Descriptive statistics for smoking behavior, stage of
change, and self-efficacy are presented in Table 1. Over
92% of participants smoked in the last seven days and
89% smoked less than one pack of cigarettes during this
time period. The median number of cigarettes smoked
per day was 15. Forty-seven percent of the sample was
nicotine dependent, and the majority was thinking about
quitting smoking–only 15% were in pre-contemplation,
22% were in contemplation and 63% were in prepara-
tion. Among those in contemplation, 45% were some-
what or very confident that they could quit smoking in
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were somewhat or very confident that they could quit
smoking in the next month. Because of our eligibility
criteria, no participants were in the stages of action or
maintenance at baseline.
Multivariate Analysis
Smoking rate
In the model to predict the number of cigarettes
smoked per week, a more lenient smoking policy at
work, encouragement to quit smoking from one’s family
and oncologist and relatively low self-efficacy to quit
smoking were all associated with increased odds of
smoking more cigarettes, whereas being hospitalized for
a medical problem was associated with a decreased odds
of smoking more cigarettes (Table 2). Stage of change,
household smoking policy, fear of cancer recurrence,
intrusive thoughts, perceived control, perceived vulner-
ability, BMI and contact with the healthcare system
were not associated with smoking rate.
Nicotine dependence
In the model to predict nicotine dependence, lack of
healthcare provider for non-emergency care, being hos-
pitalized in the past year, no fear of cancer recurrence,
no rules about smoking in the house, and low self-effi-
cacy to quit smoking in the next month were all asso-
ciated with increased odds of being nicotine dependent
(Table 3). Stage of change, social support for smoking
cessation, workplace smoking policy, intrusive thoughts,
perceived control, perceived vulnerability, depression,
and BMI were not associated with the odds of being
nicotine dependent.
Quit attempts
In the model to predict number of quit attempts in the
past 12 months, low perceived vulnerability, BMI, social
support for smoking cessation from participants’ regular
doctor and oncologist and being in a later stage of
change were associated with an increased odds of mak-
ing more quit attempts (Table 4). Self-efficacy, work-
place and household smoking policy, fear of cancer
recurrence, intrusive thoughts, perceived control,
depression, and contact with the healthcare system were
not associated with number of quit attempts.
Discussion/Conclusions
Over 90% of our sample of childhood and young adult
cancer survivors smoked within the past seven days, but
overall the smoking rate of the sample was light, with
the vast majority smoking less than one pack per week.
However, almost half of the participants were classified
as nicotine dependent. Participants in the current study
smoked fewer cigarettes than has been found in other
studies of childhood cancer survivors [15,18]. Although
we can not definitely determine the reason for this dif-
ference, there are several possible explanations. First,
s e v e r a ly e a r sh a v ep a s s e ds i n c et h el a s tr e p o r to fc h i l d -
hood cancer survivors’ smoking behavior was published.
National data suggests that the prevalence of tobacco
use has decreased during this period for the United
States population and for cancer survivors as a collective
group [31,32]. Smoking rates for childhood and young
adult cancer survivors could have declined at an acceler-
ated rate, which would be consistent with historical data
on tobacco use trends among young adults [32]. Second,
data on the late effects of cancer treatment are increas-
ingly becoming available. Childhood and young adult
cancer survivors may be responding to these data by
limiting their tobacco use to decrease their risk for
Table 1 Frequency of smoking behavior, stage of change,
and self-efficacy for smoking cessation (N = 374)
N%
Smoked in the past 7 days 346 92.51
Average number of cigarettes smoked in past 7 days
1
0-4 84 22.46
5-9 57 15.24
10-14 67 17.91
15-20 100 26.74
>20 39 10.43
Number of minutes after waking until first cigarette
2
< 30 126 33.69
≥ 30 242 64.71
Number of quit attempts in previous 12 months
3
0 162 44.88
1-3 131 36.29
≥4 68 18.84
Tried NRT
4 to quit smoking 133 35.56
Tried Zyban to quit smoking 41 10.99
Contemplation stage of change (e.g., seriously thinking
about quitting smoking in the next 6 months)
312 84.78
Preparation stage of change (e.g., seriously thinking about
quitting smoking in the next month)
230 62.50
Self-efficacy to quit in the next 6 months
Not at all confident 33 8.87
A little confident 54 14.52
Somewhat confident 117 31.45
Very confident 83 22.31
Extremely confident 85 22.85
Self-efficacy to quit in the next month
Not at all confident 84 22.58
A little confident 82 22.04
Somewhat confident 87 23.39
Very confident 60 16.13
Extremely confident 59 15.86
1 6 missing
2 4 missing
3 13 missing
4 NRT = nicotine replacement therapy
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tine dependent may be more likely to reduce their
smoking rate, rather than quit smoking, to minimize
their risk for late effects, which explains why we saw
high rates of nicotine dependence (65%) despite a low
smoking rate. Third, the low smoking rate may reflect
survivors’ efforts to quit as data suggest that some smo-
kers will decrease the amount of cigarettes they smoke
before quitting completely [33]. Finally, the low smoking
rate may also reflect selection bias such that lighter
smokers may have been more willing to participate in a
smoking cessation intervention. Regardless, there is no
research on suggesting that even light smoking is safe
for childhood cancer survivors ;t h u s ,i ti si m p o r t a n tt o
help this high-risk population refrain from tobacco use
completely.
The majority of our sample was motivated to quit
smoking–22% were in contemplation and 63% were in
preparation. However, less than one half of participants
in contemplation and preparation were very or extre-
mely confident that they could quit. Over half of survi-
vors made at least one quit attempt in the previous 12
months and about 20% made four or more quit
attempts. Collectively, these data suggest that childhood
and young adult cancer survivors in this study are moti-
vated to quit, and may benefit from a targeted and tai-
lored smoking cessation intervention to help them build
self-efficacy and quit successfully. We anticipate that the
web-based format of PFH-2 will be an accessible deliv-
ery channel for this population because of the wide-
spread access and utilization of the Internet.
In our multivariate analysis of the baseline data, stage
of change and self-efficacy were associated with smoking
behaviors. Cancer survivorsi na ne a r l ys t a g eo fc h a n g e
for smoking cessation made fewer attempts to quit
smoking. Further, survivors with low self-efficacy to quit
smoking smoked more cigarettes per week, and there
w a se v i d e n c et h a tt h e yw e r em o r el i k e l yt ob en i c o t i n e
dependent. These results are consistent with research
finding that a later stage of change and high self-efficacy
were consistently associated with smoking cessation [34]
as well as literature on the importance of tailoring
smoking cessation interventions to smokers’ stage of
change [35].
Table 2 Odds ratios predicting number of cigarettes smoked per week (n = 336)
1, 2
>1 0v .≤ 5 >10 v. 6-10 6-10 v. ≤ 5
OR (95% CI) OR (95% CI) OR (95% CI)
Hospitalized for medical problem (no = ref) 0.37 (0.10, 1.37) 0.19 (0.06, 0.60) 1.92 (0.61, 6.04)
Depression (no = ref) 2.39 (0.98, 5.83) 0.90 (0.42, 1.91) 2.66 (1.15, 6.16)
Smoking policy at work (forbidden to smoke inside = ref)
There are no rules 2.84 (0.71, 11.40) 1.91 (0.55, 6.61) 1.49 (0.44, 5.01)
People can only smoke in certain rooms or areas 7.65 (1.74, 33.64) 1.43 (0.50, 4.08) 5.34 (1.13, 25.19)
Did not work in past year 0.29 (0.09, 0.91) 1.18 (0.46, 3.05) 0.24 (0.08, 0.73)
Social support from family (ref = no). 6.48 (2.24, 18.80) 1.41 (0.55, 3.62) 4.58 (1.62, 12.98)
Social support from oncologist (ref = no) 3.40 (1.24, 9.34) 0.58 (0.26, 1.32) 5.83 (2.17, 15.65)
Self-efficacy: Level of confidence to quit smoking in 6 months (ref = very or extremely
confident)
Not at all confident 5.28 (0.54, 51.68) 1.55 (0.25, 9.23) 3.41 (0.35, 33.22)
A little or somewhat confident 1.26 (0.44, 3.61) 0.33 (0.12, 0.89) 3.85 (1.34, 11.16)
Self-efficacy: Level confidence to quit smoking in 1 month (ref = very or extremely
confident)
Not at all confident 4.60 (0.99, 21.42) 1.44 (0.32, 6.48) 3.20 (0.77, 13.30)
A little or somewhat confident 8.78 (2.39, 32.25) 2.71 (0.83, 8.92) 3.23 (1.00, 10.46)
1Adjusted for recruitment site, age, gender, race, education, treatment, diagnosis, nicotine dependence and quit attempts.
2 n = 102 survivors smoked ≤ 5 cigarettes per day; n = 90 survivors smoked between 6-10 cigarettes per day; and n = 155 survivors smoked >10 cigarettes per day.
Table 3 Odds ratios predicting nicotine dependence
(n = 348)
1
Nicotine
Dependence
OR (95% CI)
Health care provider for non-emergency care
(yes = ref)
1.96 (0.94, 4.08)
Hospitalized for medical problem in past year
(no = ref)
2.56 (1.16, 5.63)
Fear of cancer recurrence (yes = ref) 2.08 (0.81, 5.32)
Smoking policy at home (forbidden to smoke inside = ref)
There are no rules 2.19 (1.12, 4.26)
People can only smoke in certain rooms
or areas
1.94 (0.87, 4.31)
Self-efficacy: level of confidence to quit smoking in 1 month
(ref = very or extremely confident)
Not at all 1.99 (0.84, 4.70)
A little/somewhat 0.74 (0.33, 1.67)
1Adjusted for recruitment site, age, gender, race, education, treatment,
diagnosis, number of cigarettes smoked per day and quit attempts.
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with smoking behavior. Survivors who smoked more
were more likely to have received social support to quit
smoking from their family and oncologist. It is possible
that survivors who smoked more may have triggered
family and health care providers to encourage them to
quit smoking. In fact, encouragement to quit smoking
by one’s regular doctor or oncologist was associated
with a making more quit attempts. These data are con-
sistent with Emmons et al., (2003) who found that social
support for quitting smoking was associated with higher
smoking rates but more quit attempts [18].
Other evidence for the importance of the social envir-
onment came from our data on household and work-
place smoking policies. Survivors with a less stringent
smoking policy at work were more likely to smoke
more, whereas survivors with a less stringent smoking
policy at home were more likely to be nicotine depen-
dent. Workplace smoking bans make it more difficult to
s m o k ed u r i n gt h ed a ya n dm a yf a c i l i t a t es o c i a ln o r m s
around not smoking. Moreover, people employed in
workplaces with smoking bans are more likely to smoke
fewer cigarettes and think about quitting [36]. House-
hold smoking bans may reflect pressure from the smo-
ker’s family for them to quit or the smoker’s readiness
to quit. Regardless, smokers who enact household smok-
ing bans are more likely to make successful quit
attempts and have lower risk of relapse [37,38].
Survivors’ psychosocial characteristics were also asso-
ciated with their smoking behavior. Survivors who did
n o tf e a rc a n c e rr e c u r r e n c ew e r em o r el i k e l yt ob en i c o -
tine dependent; and survivors who felt more certain that
they would experience a serious future health event
made fewer quit attempts. These findings appear some-
what contradictory. The literature suggests that survi-
vors with lower risk perception may be less motivated
to change their smoking behavior than smokers with a
greater perceived risk of future health problems [39],
which is consistent with our finding for cancer recur-
rence. However, it is possible that survivors who feel
relatively certain that they will experience a future
health event are demonstrating fatalistic beliefs about
their future health potential, which are associated with a
increased likelihood of smoking and an earlier stage of
change for smoking cessation [40].
Survivors who had been hospitalized for a medical
problem in the last year were less likely to be relatively
heavy smokers but more likely to be nicotine dependent.
In addition, survivors who lacked a healthcare provider
for non-emergency care were more likely to be nicotine
dependent. Survivors who do not have access to a pri-
mary care provider (PCP) may not receive consistent
messages about the importance of making healthy life-
style choices such as quitting smoking. In addition, sur-
vivors who lack a PCP may not have the same level of
access to pharmacotherapy and behavioral interventions
for smoking cessation as survivors with a PCP.
Our findings provide important information about fac-
tors that are associated with smoking behavior among
childhood cancer survivors. In addition, our results indi-
cate that smoking cessation interventions developed for
childhood cancer survivors need to enhance motivation
to quit by providing accurate information about the
relationship between smoking and future health pro-
blems as well as the fact that smoking is particularly
harmful for cancer survivors. Coupled with efforts to
increase survivors’ perceived susceptibility to tobacco-
related health problems, interventions must help survi-
vors build self-efficacy for quitting smoking by addres-
sing their psychological barriers to quitting, increasing
social support for smoking cessation, and targeting
aspects of the social environment that can constrain
smoking behavior (e.g., household smoking policy). In
addition, even though study participants tended to be
Table 4 Odds ratios predicting quit attempts during the past 12 months (n = 339)
1
Quit Attempts During the Past 12 Months
>4 vs 0 > 4 vs 1-3 1-3 vs 0
OR (95% CI) OR (95% CI) OR (95% CI)
Perceived vulnerability (≤ unlikely = ref)
Moderate chance 0.98 (0.34, 2.77) 0.95 (0.36, 2.49) 1.03 (0.46, 2.30)
Likely 0.47 (0.15, 1.46) 0.49 (0.16, 1.48) 0.96 (0.42, 2.19)
Very likely/certain to happen 0.73 (0.26, 2.02) 2.05 (0.71, 5.95) 0.35 (0.15, 0.85)
BMI 1.09 (1.02, 1.16) 1.05 (0.98, 1.12) 1.04 (0.99, 1.09)
Social support from regular doctor (no = ref) 1.28 (0.59, 2.79) 0.57 (0.27,1.21) 2.23 (1.22, 4.10)
Social support from oncologist (no = ref) 3.08 (1.30, 7.27) 2.71 (1.12, 6.57) 1.14 (0.56, 2.29)
Stages of change (precontemplation = ref)
contemplation 1.47 (0.29, 7.47) 0.41 (0.07, 2.47) 3.57 (1.26, 10.06)
preparation 11.34 (2.88, 44.67) 1.69 (0.38, 7.46) 6.70 (2.56, 17.54)
1Adjusted for recruitment site, age, gender, race, education, treatment, diagnosis, number of cigarettes smoked per day and nicotine dependence.
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Page 7 of 9light smokers, there are high rates of nicotine depen-
dence in this group, suggesting that pharmacotherapy
may facilitate quitting.
Limitations
This study had several limitations. First, we were unable
to contact 24% of survivors who were identified by parti-
cipating sites and did not opt out, and we do not know
whether these individuals were eligible for the study. Our
study population is young adults who tend to be very
mobile and likely living in a different location from the
time of their initial treatment. In many cases, the partici-
pating sites did not have accurate addresses on file for
their patients. We made a concerted effort to locate these
individuals by using internet searches and other tele-
phone and mail-based tracing approaches. However,
despite this effort, in some cases, our strategies were
unsuccessful. Second, 48% of eligible survivors declined
to participate, which introduces selection bias into the
study; however, a 52% recruitment rate among a sample
of smokers who have not sought out smoking cessation
treatment is reasonable. Third, our sample may not be
representative of all childhood and young adult cancer
survivors who smoke because lighter smokers may have
been more willing to participate in this study than hea-
vier smokers. Results should be interpreted accordingly.
Third, our sample was predominately white, which limits
our ability to generalize to other racial and ethnic groups,
although it reflects the racial/ethnic characteristics of the
participating treatment sites.
Strengths
This study also had several important strengths. First,
study participants were recruited from five pediatric and
young adult cancer treatment facilities in the United
States and Canada. Thus, our results have higher exter-
nal validity than if recruited from a single site. Second,
we collected data on participants’ level of motivation to
quit smoking and confidence in their ability to quit
smoking in order to tailor intervention content. This
will help us evaluate whether the intervention affected
theoretical mediators of smoking cessation and better
understand the pathways through which the PFH -2
content affected smoking behavior.
Conclusions
T h er e s u l t so ft h i ss t u d ys u g g e s tt h a tah i g hp r o p o r t i o n
of childhood cancer survivors are nicotine dependent,
yet motivated to quit. Thus,t h e ym a yb e n e f i tf r o ma
targeted and tailored smoking cessation intervention to
help them quit successfully. We anticipate that the web-
based format of PFH -2 will be an accessible delivery
channel for this population because of the widespread
access and utilization of the Internet.
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